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A B S T R A C T
Parathyroid carcinoma (PC) is one of the rarest malignancies making approximately 0.005% of all cancers. It
may arise sporadically or less commonly, in conjunction with genetic endocrine syndromes. Due to the rarity of
the disease, no general consensus or definitive guidelines exist for its pre-operative diagnosis, management, or
follow up. Surgical tumor removal is the gold standard treatment to prevent its recurrence. Parathyroid carci-
noma has a high recurrence rate ranging from 40 to 60% in recent literature. We report a case of a seventy-year-
old elderly female with locally advanced parathyroid carcinoma successfully surgically excised completely with
a 3 year disease free survival period without adjuvant chemotherapy or radiotherapy.
1. Introduction
Parathyroid carcinoma (PC) is one of the rarest malignancies
making approximately 0.005% of all cancers [1,2]. Recent literature
suggests that it accounts for only 0.5–5% of all the cases of primary
hyperparathyroidism, with less than 1000 cases reported in the litera-
ture since it was first discovered in 1904 [3–5]. It may arise spor-
adically or less commonly, in conjunction with genetic endocrine syn-
dromes such as multiple endocrine neoplasia (MEN) type 1, type 2A,
and hyperparathyroidism jaw-tumor syndrome (HPT-JT) [6–8]. Diag-
nosis is usually difficult and challenging due to the absence of clinical
and radiological characteristics that reliably distinguish benign from
malignant disease [1,2,6]. Due to the rarity of the disease, no general
consensus or definitive guidelines exist for its diagnosis, management,
or follow up [6,8,9].
According to recent literature, 90% of parathyroid carcinoma cases
are hormonally functional on presentation with clinically apparent
symptoms of hypercalcemia and severe primary hyperparathyroidism
which include anxiety, depression, loss of appetite, and weight loss
usually present with the renal and skeletal disease [4,6,10]. Serum
calcium is often elevated with greater than 14mg/dl and serum para-
thyroid hormone is often raised to about three to ten times the upper
limit of normal [1]. Surgery is the mainstay of treatment with complete
resection of the tumor to achieve microscopically negative margins to
prevent recurrence [1,2,6,7,11].
We report a case of an elderly female who presented to us with
initial suspicion of parathyroid adenoma. However, post-operatively
she was diagnosed with parathyroid carcinoma on histopathological
examination.
2. Case report
This is a case of 70 years old female, with no known co-morbidities,
who presented to the Otolaryngology clinic with complaints of in-
creased somnolence and reduced appetite for past the 3–4 years. These
complaints were not associated with any other associated symptoms.
Her past medical history and family history were unremarkable. She
had a history of the cesarean section under spinal anesthesia 30 years
ago. On examination, she was well oriented to time, place, and person.
She had a heart rate of 64 beats per min, a respiratory rate of 16 breaths
per min, a blood pressure of 110/70 mm Hg, and she was afebrile. Her
general physical and systemic examination was also unremarkable. Her
serum calcium was 14.1mg/dl (8.8–10.6) and serum parathyroid hor-
mone showed a value of 457mg/dl (7-53). Her vitamin D level, serum
albumin, and creatinine were all within a normal range. 24-hour ur-
inary calcium and phosphorus were also within normal limits. She
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underwent neck ultrasonography which showed a complex solid and a
cystic nodule on the left side close to the lower pole of the thyroid
measuring 3.6 × 2.8 cm (Fig. 1).
The clinical picture was suggestive of a parathyroid adenoma and
she was admitted electively for its resection. After relevant investiga-
tions and anesthesia fitness, she underwent complete excision of the left
parathyroid lesion and left lobectomy of thyroid gland under general
anesthesia. Intra-operative findings were enlarged left parathyroid
gland which was inseparable from the multi-nodular left lobe of the
thyroid gland. A recurrent laryngeal nerve was identified and saved.
Neck drain was placed and the sample was sent for histopathology
(Fig. 2). The lesion was not involving any other structure other than the
thyroid gland. No level VI lymphadenopathy was observed in-
traoperatively.
The patient remained hemodynamically stable with no signs of re-
current laryngeal nerve palsy. Her post-op serial serum calcium mon-
itoring was done which decreased to normal range and remained
normal. No other signs of hypocalcemia were noted and serum calcium
was within a normal range. The patient remained stable and hence was
discharged as post-op day 2 on oral calcium supplements and analgesia.
At 1-week follow-up her serum calcium was 8.9mg/dl and serum
parathyroid hormone was 16.3pg/ml. Histopathology revealed a neo-
plastic lesion composed of closely space clusters of medium-sized ovoid
to polygonal cells with pale to mildly eosinophilic cytoplasm, distinct
cell borders, and centrally placed round to ovoid nuclei showing pro-
minent nucleoli. Moderate cytological atypia and nuclear pleo-
morphism were seen. Occasional mitotic figures were consistent with
parathyroid carcinoma. The tumor was seen invading into the thyroid
parenchyma 0.4cm away from the resection/capsular margin
(Fig. 3).Her repeat serum calcium was also within the normal range.
MEN syndrome workup was done which was negative. The patient was
seen regularly for 1 year and then has been on regular follow up yearly
for past three years. She has been doing well with no symptoms and
signs for recurrence of disease. Hence she has an overall disease free
survival of three years with only complete surgical resection of tumor
and no chemotherapy or radiotherapy.
3. Discussion
Parathyroid carcinoma (PC) is one of the rarest endocrine malig-
nancies with an incidence of 0.015 per 100,000 population in the
United States [1,12]. These tumors are hormonally functional with less
than 38 cases reported in the literature for non-functional parathyroid
carcinoma [6]. Hence patients often present with signs and symptoms
of hypercalcemia hyperparathyroidism [6]. Multiple case series suggest
the involvement of renal and skeletal disease in up to 50% of patients in
parathyroid carcinoma with an incidence of nephrolithiasis and renal
insufficiency as high as 56 and 84% respectively [13]. Recent studies
also suggest the presence of a palpable cervical mass in about 30–76%
of patients while the incidence of completely asymptomatic parathyroid
carcinoma described in 7–46% of patients and approximately 25% of
patients develop distant metastases at some point during the disease
[6,18]. In contrast, our patient had a hormonally functioning para-
thyroid carcinoma but she did not develop renal or skeletal disease
despite advanced age and did not have a palpable neck mass.
The pre-operative diagnosis of parathyroid carcinoma is difficult
and challenging due to the absence of diagnostic criteria and a lack of
consensus in literature [8,9]. It should be suspected in a patient with a
very high serum calcium level of greater than 14mg/dl or an increased
parathyroid hormone of greater than three to ten times of upper limit of
normal palpable cervical lymph nodes should also raise suspicion of PC
[9,14]. Neck ultrasonography and parathyroid scintigraphy have been
described as the imaging of choice for detecting parathyroid lesions and
a combination of both raises diagnostic accuracy and sensitivity; how-
ever, they cannot reliably distinguish benign from malignant disease
[6,8,11]. A size of greater than 3cm on ultrasonography should raise a
suspicion of PC [15]. Fine needle aspiration cytology should be avoided
in lesions that are suspected to be PC as it increases the risk of needle
tract dissemination, parathyromatosis, and recurrence [6]. Hence the
post-operative diagnosis of parathyroid carcinoma on histopathological
examination appears to be a norm rather than the exception [6].
The gold standard for the treatment of parathyroid carcinoma is
complete surgical excision of the tumor achieving microscopically ne-
gative margins. There is a limited role of chemotherapeutic agents and
radiotherapy in uncomplicated cases [6,7,9,16]. There is a lack of
evidence on prophylactic neck dissection. The incidence of neck me-
tastasis has been reported to be 1–6% [6].
There is a high rate of locoregional recurrence rate ranging from 40
to 60% with nearly half of patients developing distant metastasis
[7,17]. Recurrence of the tumor is common within 2–3 years of initial
surgery. A close follow up and tumor surveillance is required. Serial
neck ultrasonography, serum calcium, phosphate, and parathyroid le-
vels are required [6] 5- year disease-free survival rate after complete
Fig. 1. A 3.6 × 2.8cm complex solid and cystic nodule is seen on left side close
to left lower margin of thyroid measuring.
Fig. 2. Parathyroid carcinoma along with thyroid lobe after resection.
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surgical removal ranges from 76% to 85% [6]. This data is similar to
our case described here as our patient has a disease free survival of
three years after only complete surgical excision of tumor without ad-
juvant chemotherapy or radiotherapy and is still on regular follow ups.
4. Conclusion
The case of parathyroid carcinoma described here presents two
unique features. Parathyroid cancer may present as a parathyroid
adenoma and hence complete surgical excision of suspicious malignant
lesion intra-operatively and close follow up post-operatively can pro-
vide an excellent long term disease free survival rate in patient without
adjuvant chemotherapy or radiotherapy. Secondly, complications as-
sociated with hyperparathyroidism may be absent in parathyroid car-
cinoma. Therefore clinicians should have a high index of suspicion for
parathyroid malignant lesions if the imaging shows unusual char-
acteristics. Thyroid lobectomy should be performed to enhance the
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Fig. 3. [A] Low power view of the neoplastic lesion
exhibiting fibrous capsule (longer arrow), sheets of
cells and cystic spaces (shorter arrow) [B] The
neoplastic cells have pale to eosinopilic cytoplasm
and vesicular nuclei with inconspicuous nucleoli
[C] Few cells showed marked nuclear pleo-
morphism (arrows) [D] Focal invasion of para-
thyroid capsule (longer arrow) and extension into
thyroid tissue is also seen (shorter arrow).
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Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.amsu.2020.07.023.
References
[1] J. Goswamy, M. Lei, R. Simo, Parathyroid carcinoma, Curr. Opin. Otolaryngol.
Head Neck Surg. 24 (2) (2016 Apr 1) 155–162.
[2] N. Kolsi, S. Jellali, J. Koubaa, Parathyroid carcinoma: about a case and review of the
literature, The Pan African medical journal 27 (2017) 85.
[3] Fd Quervain, Parastruma maligna aberrata, Deutsche Zeitschrift Fuer Chirurgie 100
(1904) 334–352.
[4] B. Givi, J.P. Shah, Parathyroid carcinoma, Clinical oncology 22 (6) (2010 Aug 1)
498–507.
[5] J.M. Sharretts, E. Kebebew, W.F. Simonds, Parathyroid cancer, InSeminars in on-
cology 37 (6) (2010 Dec 1) 580–590 (WB Saunders).
[6] V. Ferraro, L.I. Sgaramella, G. Di Meo, F.P. Prete, F. Logoluso, F. Minerva,
M. Noviello, G. Renzulli, A. Gurrado, M. Testini, Current concepts in parathyroid
carcinoma: a single Centre experience, BMC Endocr. Disord. 19 (1) (2019 May) 46.
[7] S. Storvall, E. Ryhänen, F.V. Bensch, I. Heiskanen, S. Kytölä, T. Ebeling, S. Mäkelä,
C. Schalin‐Jäntti, Recurrent metastasized parathyroid carcinoma—long‐term re-
mission after combined treatments with surgery, radiotherapy, cinacalcet, zole-
dronic acid, and temozolomide, JBMR plus 3 (4) (2019 Apr) e10114.
[8] A. Campennì, S. Giovinazzo, S.A. Pignata, F. Di Mauro, D. Santoro, L. Curtò,
F. Trimarchi, R.M. Ruggeri, S. Baldari, Association of parathyroid carcinoma and
thyroid disorders: a clinical review, Endocrine 56 (1) (2017 Apr 1) 19–26.
[9] S. Pramanik, S. Ray, R. Bhattacharjee, S. Chowdhury, Parathyroid carcinoma and
persistent hypercalcemia: a case report and review of therapeutic options, Saudi
journal of medicine & medical sciences 6 (2) (2018 May) 115.
[10] W.C. Dudney, D. Bodenner, B.C. Stack Jr., Parathyroid carcinoma, Otolaryngol Clin
N Am 43 (2) (2010) 441–453 xi.
[11] N.T. Thanseer, A.S. Parihar, A. Sood, S.K. Bhadada, D. Dahiya, P. Singh, B.R. Mittal,
Evaluation of recurrent parathyroid carcinoma: a new imaging tool in uncommon
entity, World J. Nucl. Med. 18 (2) (2019 Apr) 198.
[12] S.A. Hundahl, et al., Two hundred eighty-six cases of parathyroid carcinoma treated
in the U.S. Between 1985-1995: a national cancer data base report. The American
college of surgeons commission on cancer and the American cancer society, Cancer
86 (3) (1999) 538–544.
[13] A.G. Wynne, et al., Parathyroid carcinoma: clinical and pathologic features in 43
patients, Medicine (Baltim.) 71 (4) (1992) 197–205.
[14] T. Obara, Y. Fujimoto, Diagnosis and treatment of patients with parathyroid car-
cinoma: an update and review, World J. Surg. 15 (1991) 738–744.
[15] J.H. Kwon, et al., Neck ultrasonography as preoperative localization of primary
hyperparathyroidism with an additional role of detecting thyroid malignancy, Eur.
J. Radiol. 82 (1) (2013) e17–21.
[16] E. Shane, Parathyroid carcinoma, Curr Ther Endocrinol Metab 5 (1994) 522–525.
[17] K. Sandelin, O. Tullgren, L.O. Farnebo, Clinical course of metastatic parathyroid
cancer, World J. Surg. 18 (4) (1994) 594–598 discussion 599.
[18] J.M. Sharretts, E. Kebebew, W.F. Simonds, Parathyroid cancer, Semin. Oncol. 37 (6)
(2010) 580‐590.
[19] R.A. Agha, M.R. Borrelli, R. Farwana, K. Koshy, A. Fowler, D.P. Orgill, For the
SCARE Group, The SCARE 2018 statement: updating consensus surgical CAse
REport (SCARE) guidelines, Int. J. Surg. 60 (2018) 132–136.
A.A. Sohail, et al. Annals of Medicine and Surgery 57 (2020) 62–65
65
